tetradecanoylphorbol acetate has been researched along with plumbagin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chang, WT; Chao, CH; Chiang, TA; Huang, GY; Lee, YC; Shieh, JM; Shih, YW; Shih, YX | 1 |
| Kawamura, M; Kuramochi, K; Kuriyama, I; Mizushina, Y; Naganune, H; Onodera, T; Sakamoto, Y; Tabata, A; Tsubaki, K | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and plumbagin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells.
Topics: Cell Line, Tumor; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 3; Naphthoquinones; NF-kappa B; Phosphorylation; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator | 2010 |
5-O-Acyl plumbagins inhibit DNA polymerase activity and suppress the inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; DNA Polymerase beta; Escherichia coli Proteins; Fatty Acids; Gene Knockdown Techniques; Humans; Inflammation; Lipopolysaccharides; Macrophages; Mice; Naphthoquinones; Plant Proteins; Rats; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2015 |